Related Experiment Videos
[A clinical evaluation of cefdinir in pediatric infections]
1Department of Pediatrics, Yamagata City Hospital-Saiseikan.
Insights
Cefdinir (CFDN), a novel oral cephalosporin, demonstrated 100% clinical efficacy in treating various infections. This new antibiotic showed excellent safety with no observed side effects in patients.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Cefdinir (CFDN) is an emerging oral cephalosporin antibiotic.
- Bacterial infections pose a significant public health challenge.
- Effective and safe antimicrobial agents are crucial for treatment.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of Cefdinir (CFDN).
- To assess the antimicrobial activity of CFDN against common bacterial pathogens.
Main Methods:
- Cefdinir (CFDN) was administered to 10 patients diagnosed with diverse infections.
- Clinical outcomes and bacterial eradication were monitored.
- Adverse events and laboratory values were assessed for safety evaluation.
Main Results:
- 100% clinical efficacy was observed, with 6 excellent and 4 good responses.
- Bacterial eradication was achieved for all isolated pathogens, including Staphylococcus aureus, Streptococcus pyogenes, and Haemophilus influenzae.
- No adverse effects or abnormal laboratory findings were reported, indicating a favorable safety profile.
Conclusions:
- Cefdinir (CFDN) is a highly effective and safe oral antibiotic for treating various bacterial infections.
- The drug demonstrated potent activity against key pathogens, supporting its clinical utility.
- Further research may explore its role in broader infectious disease management.
Abstract:
Cefdinir (CFDN), a new oral cephalosporin, was administered to 10 patients with various infections and the following results were obtained. 1. Clinical responses in 10 patients (1 patient with rhinitis, 2 with sinusitis, 1 with pharyngitis, 1 with tonsillitis, 4 with scarlet fever and 1 with abscess) were excellent in 6 and good in 4 with an efficacy rate of 100%. 2. Eleven species of bacteria were isolated (3 of Staphylococcus aureus, 6 of Streptococcus pyogenes and 2 of Haemophilus influenzae) and all of them were eradicated by the treatment with CFDN. 3. No side effects or abnormal laboratory test values were noted. None of the patients refused to take the drug.